Susquehanna International Group, LLP Janux Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$35.29 - $50.26 $1.79 Million - $2.54 Million	50,600 Added 73.98%	119,000 $5.41 Million
Q2 2024 Aug 15, 2024	SELL	$35.12 - $64.78 $744,544 - $1.37 Million	-21,200 Reduced 23.66%	68,400 $2.87 Million
Q1 2024 May 07, 2024	BUY	$7.93 - $49.75 $710,528 - $4.46 Million	89,600 New	89,600 $3.37 Million

166

37.6M

85.3K

654K

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $2.1B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.